Group IV Bimetallic MOFs Engineering Enhanced Metabolic Profiles Co‐Predict Liposarcoma Recognition and Classification
Small Methods · 2025-04 · 9 (4)
DOI: 10.1002/smtd.202401421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 06.01.2025. Verfasst von Heyuhan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Department of Institutes of Biomedical Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Liposarcoma, Metal-Organic Frameworks, Metabolome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program, Young Talents-Training Plan of Shanghai Traditional Chinese Medicine-Integrated Hospital.
Abstract (Originalsprache)
The rarity and heterogeneity of liposarcomas (LPS) pose significant challenges in their diagnosis and management. In this work, a series of metal–organic frameworks (MOFs) engineering is designed and implemented. Through comprehensive characterization and performance evaluations, such as stability, thermal‐driven desorption efficiency, as well as energy‐ and charge‐transfer capacity, the engineering of group IV bimetallic MOFs emerges as particularly noteworthy. This is especially true for their derivative products, which exhibit superior performance across a range of laser desorption/ionization mass spectrometry (LDI MS) performance tests, including those involving practical sample assessments. The top‐performing product is utilized to enable high‐throughput recording of LPS metabolic fingerprints (PMFs) within seconds using LDI MS. With machine learning on PMFs, both the LPSrecognizer and LPSclassifier are developed, achieving accurate recognition and classification of LPS with area under the curves (AUCs) of 0.900–1.000. Simplified versions are also developed of the LPSrecognizer and LPSclassifier by screening metabolic biomarker panels, achieving considerable predictive performance, and conducting basic pathway exploration. The work highlights the MOFs engineering for the matrix design and their potential application in developing metabolic analysis and screening tools for rare diseases in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Department of Institutes of Biomedical Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200433, China.
- Department of Laboratory Medicine, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200082, China.
- Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Department of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361006, China.
- Xiamen Clinical Research Center for Cancer Therapy, Xiamen, 361006, China.
- Department of Gastroenterology and Hepatology, Zhongshan Hospital, Department of Chemistry, Department of Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Chunhui Deng
Förderung
- National Natural Science Foundation of China
- Shanghai Sailing Program
- Young Talents-Training Plan of Shanghai Traditional Chinese Medicine-Integrated Hospital
- Natural Science Foundation of Fujian province
Zitieren
APA
Zhang, H., Tao, P., Tong, H., Zhang, Y., Sun, N., & Deng, C. (2025). Group IV Bimetallic MOFs Engineering Enhanced Metabolic Profiles Co‐Predict Liposarcoma Recognition and Classification. Small Methods, 9(4). https://doi.org/10.1002/smtd.202401421
Vancouver
Zhang H, Tao P, Tong H, Zhang Y, Sun N, Deng C. Group IV Bimetallic MOFs Engineering Enhanced Metabolic Profiles Co‐Predict Liposarcoma Recognition and Classification. Small Methods. 2025;9(4). doi:10.1002/smtd.202401421
BibTeX
@article{Zhang2025,
author = {Zhang, Heyuhan and Tao, Ping and Tong, Hanxing and Zhang, Yong and Sun, Nianrong and Deng, Chunhui},
title = {Group IV Bimetallic MOFs Engineering Enhanced Metabolic Profiles Co‐Predict Liposarcoma Recognition and Classification},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {4},
doi = {10.1002/smtd.202401421}
}
EUVIMED